Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic ...

Early-stage stomach cancer often has no symptoms ... Stomach cancer accounts for about 1.3 percent of all new cancers diagnosed each year in the United States and is far less common than many ...

Men are particularly at a higher risk, being three times more likely to develop stomach cancer compared to women. Stomach ...

A mom has opened up about being diagnosed with stage three cancer in her 30s in the hope of warning others after she ignored ...